NBIX icon

Neurocrine Biosciences

198 hedge funds and large institutions have $3.98B invested in Neurocrine Biosciences in 2015 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 87 increasing their positions, 52 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
198
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$61.7M
Puts
$18.9M
Net Calls
Net Calls Change

Top Buyers

1 +$67.8M
2 +$20.1M
3 +$19M
4
VOYA Investment Management
VOYA Investment Management
Georgia
+$16.6M
5
Norges Bank
Norges Bank
Norway
+$14.1M

Top Sellers

1 -$53.2M
2 -$48.4M
3 -$39.6M
4
O
OrbiMed
New York
-$35.3M
5
PA
Perceptive Advisors
New York
-$21.8M
Name Holding Trade Value Shares
Change
Change in
Stake
151
$450K
152
$450K
153
$430K
154
$422K
155
$412K
156
$410K
157
$389K
158
$377K
159
$369K
160
$339K
161
$337K
162
$321K
163
$315K
164
$312K
165
$286K
166
$263K
167
$241K
168
$239K
169
$215K
170
$209K
171
$198K
172
$156K
173
$131K
174
$126K
175
$123K